September 05, 2019

Zafgen

Zafgen to Explore Strategic Alternatives

September 05, 2019

Sage Therapeutics

Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

September 05, 2019

Neon Therapeutics

Neon Therapeutics Announces Publication in Immunity of Novel Approach to Predict MHC Class II Cancer-Specific Neoantigens

September 05, 2019

GBT

GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease

September 04, 2019

Sage Therapeutics

Sage Therapeutics Announces the New England Journal of Medicine Publishes Data from Phase 2 Trial with SAGE-217 in Major Depressive Disordersa

Load More

Sign up for weekly portfolio news.